These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12623322)

  • 1. Hospital-acquired urinary tract infections in Turkey: a nationwide multicenter point prevalence study.
    Leblebicioglu H; Esen S;
    J Hosp Infect; 2003 Mar; 53(3):207-10. PubMed ID: 12623322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital-acquired urinary tract infection point prevalence in Turkey: differences in risk factors among patient groups.
    Isikgoz Tasbakan M; Durusoy R; Pullukcu H; Sipahi OR; Ulusoy S;
    Ann Clin Microbiol Antimicrob; 2013 Nov; 12():31. PubMed ID: 24188193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Etiologic agents and risk factors in nosocomial urinary tract infections].
    Akkoyun S; Kuloğlu F; Tokuç B
    Mikrobiyol Bul; 2008 Apr; 42(2):245-54. PubMed ID: 18697422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
    Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
    BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosocomial urinary tract infections: micro-organisms, antibiotic sensitivities and risk factors.
    Savas L; Guvel S; Onlen Y; Savas N; Duran N
    West Indian Med J; 2006 Jun; 55(3):188-93. PubMed ID: 17087104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the risk factors in nosocomial urinary tract infections and effect of urinary catheter use on distribution of the causative agents].
    Erben N; Alpat SN; Kartal ED; Ozgüneş I; Usluer G
    Mikrobiyol Bul; 2009 Jan; 43(1):77-82. PubMed ID: 19334383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System.
    Richards MJ; Edwards JR; Culver DH; Gaynes RP
    Crit Care Med; 1999 May; 27(5):887-92. PubMed ID: 10362409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
    Koksal I; Yilmaz G; Unal S; Zarakolu P; Korten V; Mulazimoglu L; Tabak F; Mete B; Oguz VA; Gulay Z; Alp E; Badal R; Lob S
    J Antimicrob Chemother; 2017 May; 72(5):1364-1372. PubMed ID: 28122913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nosocomial urinary tract infections in the intensive care unit patients].
    Parlak E; Erol S; Kizilkaya M; Altoparlak U; Parlak M
    Mikrobiyol Bul; 2007 Jan; 41(1):39-49. PubMed ID: 17427551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced rates of hospital-acquired UTI in medical patients. Prevalence surveys indicate effect of active infection control programmes.
    Christensen M; Jepsen OB
    J Hosp Infect; 2001 Jan; 47(1):36-40. PubMed ID: 11161896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and risk factors for multi-drug resistant hospital-acquired urinary tract infection in patients with liver cirrhosis: single center experience in Serbia.
    Milovanovic T; Dumic I; Veličkovic J; Lalosevic MS; Nikolic V; Palibrk I
    BMC Infect Dis; 2019 Feb; 19(1):141. PubMed ID: 30755176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC).
    Leblebicioglu H; Rosenthal VD; Arikan OA; Ozgültekin A; Yalcin AN; Koksal I; Usluer G; Sardan YC; Ulusoy S;
    J Hosp Infect; 2007 Mar; 65(3):251-7. PubMed ID: 17257710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of quinolone-resistant urinary tract infections in Comanche County Memorial Hospital.
    Siddiqui AA
    J Okla State Med Assoc; 2008 Sep; 101(9):210-2. PubMed ID: 18856050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
    Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
    Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary tract infection. Diabetics and non-diabetic patients.
    Akbar DH
    Saudi Med J; 2001 Apr; 22(4):326-9. PubMed ID: 11331489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-Year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analyses of Prevalence Data.
    Fasugba O; Mitchell BG; Mnatzaganian G; Das A; Collignon P; Gardner A
    PLoS One; 2016; 11(10):e0164306. PubMed ID: 27711250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). II. Background of patients].
    Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
    Jpn J Antibiot; 1996 May; 49(5):494-508. PubMed ID: 8752863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalance of and risk factors for hospital-acquired infections in Slovenia-results of the first national survey, 2001.
    Klavs I; Bufon Luznik T; Skerl M; Grgic-Vitek M; Lejko Zupanc T; Dolinsek M; Prodan V; Vegnuti M; Kraigher A; Arnez Z;
    J Hosp Infect; 2003 Jun; 54(2):149-57. PubMed ID: 12818590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.